View of Seroprevalence of Epstein-Barr Virus Antibodies and Complement C3/C4 Levels in Immunocompromised (Malignant Tumors and Organ Transplant Recipients) Patients

Return to Article Details Seroprevalence of Epstein-Barr Virus Antibodies and Complement C3/C4 Levels in Immunocompromised (Malignant Tumors and Organ Transplant Recipients) Patients Download Download PDF